About I-SPY 2

Welcome to the I-SPY 2 Trial website for patients

We hope the site will answer your questions about the I-SPY 2 Trial for breast cancer.

What is the I-SPY 2 Trial?

The I-SPY 2 Trial is an investigational drug trial for newly diagnosed patients with locally advanced breast cancer. An investigational drug has been approved for testing in people by the U.S. Food and Drug Administration (FDA) but has not yet been approved for widespread use. A clinical trial tests how well investigational drugs work and whether they are safe to use.

The I-SPY 2 Trial has three main phases: Screening, Treatment and Follow Up.

To find out more click on the arrow that describes your situation.

The I-SPY 2 Trial is sponsored by Quantum Leap Healthcare Collaborative, a 501(c)(3) charitable organization integrating high-impact clinical research with patient care.